Dr. Arthur Mourtzinos

Dr. Arthur Mourtzinos
Arthur Mourtzinos graduated from the Boston University Seven Year Combined BA/MD Program in 1999. He completed his general surgery residency at Massachusetts General Hospital, urology residency at Lahey Health and Medical Center (LHMC), and a fellowship in male and female pelvic reconstructive surgery and urinary incontinence at UCLA Medical Center. He completed his MBA with a healthcare concentration at Babson College in 2013. Dr. Mourtzinos has served as vice-chairman of the division of Urology at LHMC since 2013. He currently serves on the Lahey Foundation Board of Trustees and Parkland Medical Center Board of Trustees and is an associate professor of Urology at Tufts University School of Medicine. Dr. Mourtzinos has served as the vice-chair for physician compensation at LHMC since 2017 Dr. Mourtzinos has been in practice for 14 years performing procedures for urinary incontinence, BPH, and pelvic reconstructive surgery.

Languages Spoken:

English, Spanish, Greek

Medical School:

Boston University

Residency:

Massahusetts General Hospital and Lahey Health and Medical Center

Undergraduate:

Boston University

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only